SCHEMBL5149496

SCHEMBL5149496

O=C(O)CCn1c2ccccc2c2ccc(OCCCCOc3ccc4c(c3)CCC(=O)N4)cc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.55
MAOB P27338 7/20 0.55
PDE3B Q13370 2/20 0.50
PDE3A Q14432 2/20 0.50
DRD2 P14416 6/20 0.49
HTR1A P08908 3/20 0.49
HTR2A P28223 3/20 0.49
HTR7 P34969 3/20 0.49
HTR6 P50406 2/20 0.49
DRD3 P35462 3/20 0.49
HTR2C P28335 2/20 0.49
SLC6A4 P31645 2/20 0.49
DRD4 P21917 2/20 0.49
PSEN1 P49768 4/20 0.47
PSEN2 P49810 4/20 0.47
APH1B Q8WW43 4/20 0.47
NCSTN Q92542 4/20 0.47
APH1A Q96BI3 4/20 0.47
PSENEN Q9NZ42 4/20 0.47
FABP3 P05413 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5151332 0.90 MAOA (0.56) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL5151952 0.84 PSEN1 (0.52) MAOAMAOBHTR1AHTR2AHTR7
SCHEMBL5151921 0.82 PSEN1 (0.49) MAOAMAOBPSEN1PSEN2APH1B
SCHEMBL5151535 0.82 FABP4 (0.62) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11066098 0.81 MAOB (0.66) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL5152291 0.80 MAOB (0.54) MAOAMAOBPSEN1PSEN2APH1B
SCHEMBL11289343 0.80 MAOB (0.65) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL10900191 0.80 MAOB (0.67) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL5152180 0.79 PSEN1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151312 0.79 FABP4 (0.58) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US claimed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor PTGER2, PTGER1, PTGDR2 MAOA 2113/4885MAOB 1648/4885PDE3B 1150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.